Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Rafael Portela

Pediatric Otolaryngology Miami, FL Medical Doctor

NPI 1972599397 CMS profile 761215

3100 Sw 62Nd Ave, Suite 124, Miami, FL 33155

Open in the dashboard

General payments

$7,522

21 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Rafael Portela of Miami, FL is reported in the CMS Open Payments database as having received $7,522 across 21 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Pediatric Otolaryngology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $33 1
2021 General $72 4
2020 General $47 3
2019 General $7,370 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rafael Portela
  • Pediatric Otolaryngology median
  • Middle half of Pediatric Otolaryngology
  • National median

In program year 2025, general payments to Rafael Portela were reported at $0. Among 368 Pediatric Otolaryngology profiles paid that year, the median was $172 and the middle half received between $78 and $412.

Show as a table
Year Rafael Portela Pediatric Otolaryngology median Middle half National median
2019 $7,370 $127 $51–$271 $163
2020 $47 $64 $31–$165 $114
2021 $72 $88 $26–$225 $132
2022 $33 $122 $43–$316 $149
2023 $0 $128 $52–$340 $160
2024 $0 $150 $65–$384 $164
2025 $0 $172 $78–$412 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Smith+Nephew, Inc. $7,128 10 payments
  2. OptiNose US, Inc. $223 7 payments
  3. ALK-Abello, Inc $94 1 payment
  4. Acclarent, Inc $33 1 payment
  5. Stryker Corporation $24 1 payment
  6. Novartis Pharmaceuticals Corporation $20 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Consulting Fee $6,606 4 payments
  2. Travel and Lodging $483 3 payments
  3. Food and Beverage $433 14 payments
Products named General payments · program years 2019–2022
  1. Coblation - Sinus Wands $4,055 3 payments
  2. Coblation - Tonsil Wands $2,106 2 payments
  3. Entact $700 1 payment
  4. Coblation - Turbinate Wands $267 4 payments
  5. Xhance $223 7 payments
  6. Odactra $94 1 payment
  7. Relieva Spinplus $33 1 payment
  8. XPRESS ENT DILATION SYSTEM $24 1 payment
  9. CIPRODEX $20 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

185

Median for Otolaryngology: 297

Drug cost

$4,455

Median for Otolaryngology: $6,314

Branded share of claims

19.5%

Median for Otolaryngology: 10.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ciprofloxacin-Dexamethasone Ciprofloxacin Hcl/Dexameth Brand 19 $1,633
Ipratropium Bromide Generic 20 $874
Fluocinolone Acetonide Oil Generic 38 $804
Clotrimazole Generic 11 $468
Fluticasone Propionate Generic 63 $411
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 17 $221
Prednisone Generic 17 $45

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 9,296 Part D prescribers listed as Otolaryngology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 7 billing codes

Paid by Medicare

$14,283

Medicare's payments for the services billed

Medicare patients

98

Average age 78

Services billed

245

57 women, 41 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Arthritis 44%
Ischemic heart disease 38%
Osteoporosis 29%
Chronic kidney disease 26%
Depression 18%
Diabetes 17%
Atrial fibrillation 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

21 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Otolaryngology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record